Identification and characterization of a serious multidrug resistant stenotrophomonas maltophilia strain in china

BioMed Research International

Volumn 2015, Issue , 2015, Pages

  Zhao, Yan ^a,b   Niu, Wenkai ^a   Sun, Yanxia ^c   Hao, Huaijie ^a   Yu, Dong ^d   Xu, Guangyang ^a   Shang, Xueyi ^a   Tang, Xueping ^a   Lu, Sijing ^b   Yue, Junjie ^d   Li, Yan ^a  

^a BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

^b JINZHOU MEDICAL UNIVERSITY   (China)

^c Jinan Fourth People's Hospital   (China)

^d BEIJING INSTITUTE OF BIOTECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

QUINOLONE DERIVATIVE; SULFONAMIDE; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN;

AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENOME; BACTERIAL STRAIN; BLOOD SAMPLING; CHINA; CORRELATIONAL STUDY; GENE CASSETTE; GENE CLUSTER; GENE SEQUENCE; HUMAN; INTEGRON; MALE; MOLECULAR PHYLOGENY; MULTIDRUG RESISTANCE; PHENOTYPE; STENOTROPHOMONAS MALTOPHILIA; AMINO ACID SEQUENCE; BACTERIAL GENE; CHEMISTRY; DNA SEQUENCE; DRUG EFFECTS; GENETIC DATABASE; GENETICS; HOST PATHOGEN INTERACTION; MOLECULAR GENETICS; PHYLOGENY; SEQUENCE ALIGNMENT;

STENOTROPHOMONAS MALTOPHILIA;

AMINO ACID SEQUENCE; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; CHINA; DATABASES, GENETIC; DRUG RESISTANCE, MICROBIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GENES, BACTERIAL; HOST-PATHOGEN INTERACTIONS; HUMANS; INTEGRONS; MOLECULAR SEQUENCE DATA; PHYLOGENY; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS, DNA; STENOTROPHOMONAS MALTOPHILIA;

EID: 84947648701     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2015/580240     Document Type: Article

References (36)

1. R. P. Ryan, S. Monchy, M. Cardinale et al., "The versatility and adaptation of bacteria from the genus Stenotrophomonas," Nature Reviews Microbiology, vol. 7, no. 7, pp. 514-525, 2009.
2. J. S. Brooke, "Stenotrophomonas maltophilia: an emerging global opportunistic pathogen," Clinical Microbiology Reviews, vol. 25, no. 1, pp. 2-41, 2012.
3. L. Calza, R. Manfredi, and F. Chiodo, "Stenotrophomonas (Xanthomonas) maltophilia as an emerging opportunistic pathogen in association with HIV infection: a 10-year surveillance study," Infection, vol. 31, no. 3, pp. 155-161, 2003.
4. P. Naidu and S. Smith, "A review of 11 years of Stenotrophomonas maltophilia blood isolates at a tertiary care institute in Canada," Canadian Journal of Infectious Diseases and Medical Microbiology, vol. 23, no. 4, pp. 165-169, 2012.
5. V. J. Waters, M. I. Gómez, G. Soong, S. Amin, R. K. Ernst, and A. Prince, "Immunostimulatory properties of the emerging pathogen Stenotrophomonas maltophilia," Infection and Immunity, vol. 75, no. 4, pp. 1698-1703, 2007.
6. S. Nseir, C. Di Pompeo, H. Brisson et al., "Intensive care unitacquired Stenotrophomonas maltophilia: incidence, risk factors, and outcome," Critical Care, vol. 10, no. 5, article R143, 2006.
7. G. Samonis, D. E. Karageorgopoulos, S. Maraki et al., "Stenotrophomonas maltophilia infections in a general hospital: patient characteristics, antimicrobial susceptibility, and treatment outcome," PLoS ONE, vol. 7, no. 5, Article ID e37375, 2012.
8. T.-N. Jang, F.-D. Wang, L.-S. Wang, C.-H. Liu, and I.-M. Liu, "Xanthomonas maltophilia bacteremia: an analysis of 32 cases," Journal of the Formosan Medical Association, vol. 91, no. 12, pp. 1170-1176, 1992.
9. M. A. Victor, M. Arpi, B. Bruun, V. Jonsson, and M. M. Hansen, "Xanthomonas maltophilia bacteremia in immunocompromised hematological patients," Scandinavian Journal of Infectious Diseases, vol. 26, no. 2, pp. 163-170, 1994.
10. L. C. Crossman, V. C. Gould, J. M. Dow et al., "The complete genome, comparative and functional analysis of Stenotrophomonasmaltophilia reveals an organism heavily shielded by drug resistance determinants," Genome Biology, vol. 9, no. 4, article R74, 2008.
11. C.-C. Tseng, W.-F. Fang, K.-T. Huang et al., "Risk factors for mortality in patients with nosocomial Stenotrophomonas maltophilia pneumonia," Infection Control and Hospital Epidemiology, vol. 30, no. 12, pp. 1193-1202, 2009.
12. V. C. Gould, A. Okazaki, and M. B. Avison, "Coordinate hyperproduction of SmeZ and SmeJK efflux pumps extends drug resistance in Stenotrophomonas maltophilia," Antimicrobial Agents and Chemotherapy, vol. 57, no. 1, pp. 655-657, 2013.
13. D. Sassera, I. Leardini, L. Villa et al., "Draft genome sequence of Stenotrophomonas maltophilia strain EPM1, found in association with a culture of the human parasite Giardia duodenalis," GenomeAnnouncements, vol. 1, no. 2, Article IDe00182-13, 2013.
14. A. Chauhan, S. Green, A. Pathak, J. Thomas, and R. Venkatramanan, "Whole-genome sequences of five oyster-associated bacteria show potential for crude oil hydrocarbon degradation," Genome Announcements, vol. 1, no. 5, Article ID e00802-13, 2013.
15. F. Lira, A. Hernández, E. Belda et al., "Whole-genome sequence of Stenotrophomonas maltophilia D457, a clinical isolate and a model strain," Journal of Bacteriology, vol. 194, no. 13, pp. 3563-3564, 2012.
16. L. Zhang, M. Morrison, P. O. Cuív, P. Evans, andC.M. Rickard, "Genome sequence of Stenotrophomonas maltophilia strain AU12-09, isolated from an intravascular catheter," Genome Announcements, vol. 1, no. 3, 2013.
17. R. Banerjee and D. Roy, "Codon usage and gene expression pattern of Stenotrophomonas maltophilia R551-3 for pathogenic mode of living," Biochemical and Biophysical Research Communications, vol. 390, no. 2, pp. 177-181, 2009.
18. M. Adamek, J. Overhage, S. Bathe, J. Winter, R. Fischer, and T. Schwartz, "Genotyping of environmental and clinical Stenotrophomonas maltophilia isolates and their pathogenic potentia," PLoS ONE, vol. 6, no. 11, Article ID e27615, 2011.
19. A. L. Delcher, A. Phillippy, J. Carlton, and S. L. Salzberg, "Fast algorithms for large-scale genome alignment and comparison," Nucleic Acids Research, vol. 30, no. 11, pp. 2478-2483, 2002.
20. A. G. McArthur, N. Waglechner, F. Nizam et al., "The comprehensive antibiotic resistance database," Antimicrobial Agents and Chemotherapy, vol. 57, no. 7, pp. 3348-3357, 2013.
21. L. L. Chang, H. F. Chen, C. Y. Chang, T. M. Lee, andW. J. Wu, "Contribution of integrons, and SmeABC and SmeDEF efflux pumps to multidrug resistance in clinical isolates of Stenotrophomonas maltophilia," Journal of Antimicrobial Chemotherapy, vol. 53, no. 3, pp. 518-521, 2004.
22. H. W. Stokes and R. M. Hall, "A novel family of potentially mobile DNA elements encoding site-specific gene-integration functions: integrons," Molecular Microbiology, vol. 3, no. 12, pp. 1669-1683, 1989.
23. A. C. Fluit and F. J. Schmitz, "Class 1 integrons, gene cassettes, mobility, and epidemiology," European Journal of ClinicalMicrobiology & Infectious Diseases, vol. 18, no. 11, pp. 761-770, 1999.
24. R. Barbolla, M. Catalano, B. E. Orman et al., "Class 1 integrons increase trimethoprim-sulfamethoxazole MICs against epidemiologically unrelated Stenotrophomonas maltophilia isolates," Antimicrobial Agents and Chemotherapy, vol. 48, no. 2, pp. 666-669, 2004.
25. M. A. Toleman, P. M. Bennett, D. M. C. Bennett, R.N. Jones, and T. R. Walsh, "Global emergence of trimethoprim/sulfamethoxazole resistance in Stenotrophomonas maltophilia mediated by acquisition of sul genes," Emerging Infectious Diseases, vol. 13, no. 4, pp. 559-565, 2007.
26. G. A. Jacoby, "Mechanisms of resistance to quinolones," Clinical Infectious Diseases, vol. 41, supplement 2, pp. S120-S126, 2005.
27. A. Alonso and J. L. Martínez, "Multiple antibiotic resistance in Stenotrophomonas maltophilia," Antimicrobial Agents and Chemotherapy, vol. 41, no. 5, pp. 1140-1142, 1997.
28. L. McMurry, R. E. Petrucci Jr., and S. B. Levy, "Active efflux of tetracycline encoded by four genetically different tetracyline resistance determinants in Escherichia coli," Proceedings of the National Academy of Sciences of the United States of America, vol. 77, no. 7, pp. 3974-3977, 1980.
29. J. L. Martinez, M. B. Sánchez, L. Martínez-Solano et al., "Functional role of bacterial multidrug efflux pumps in microbial natural ecosystems," FEMS Microbiology Reviews, vol. 33, no. 2, pp. 430-449, 2009.
30. M. Ferrer-Navarro, R. Planell, D. Yero et al., "Abundance of the quorum-sensing factor Ax21 in four strains of correlates with mortality rate in a New Zebrafish model of infection," PLoS ONE, vol. 8, no. 6, Article ID e67207, 2013.
31. S.W. Han, S.W. Lee, and P. C. Ronald, "Secretion, modification, and regulation of Ax21," Current Opinion in Microbiology, vol. 14, no. 1, pp. 62-67, 2011.
32. Lee SW, S.W. Han, M. Sririyanum, C. J. Park, Y. S. Seo, and P. C. Ronald, "A type I-secreted, sulfated peptide triggers XA21- mediated innate immunity," Science, vol. 326, no. 5954, pp. 850-853, 2009.
33. Y. McCarthy, J. M. Dow, and R. P. Ryan, "The Ax21 protein is a cell-cell signal that regulates virulence in the nosocomial pathogen Stenotrophomonas maltophilia," Journal of Bacteriology, vol. 193, no. 22, pp. 6375-6378, 2011.
34. S. Kaiser, K. Biehler, and D. Jonas, "A Stenotrophomonas maltophilia multilocus sequence typing scheme for inferring population structured," Journal of Bacteriology, vol. 191, no. 9, pp. 2934-2943, 2009.
35. M. B. Sánchez, A. Hernández, J. M. Rodríguez-Martínez, L. Martínez-Martínez, and J. L. Martínez, "Predictive analysis of transmissible quinolone resistance indicates Stenotrophomonas maltophilia as a potential source of a novel family of Qnr determinants," BMC Microbiology, vol. 8, article 148, 2008.
36. V. Ng and W.-J. Lin, "Comparison of assembled Clostridium botulinum A1 genomes revealed their evolutionary relationship," Genomics, vol. 103, no. 1, pp. 94-106, 2014.